Department of Nephrology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, D-430030, Hubei, China.
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No. 1095 Jiefang Avenue, Wuhan, D-430030, Hubei, China.
Lipids Health Dis. 2021 Sep 29;20(1):122. doi: 10.1186/s12944-021-01558-x.
Idiopathic membranous nephropathy (IMN) may have various clinical outcomes. Hyperlipidemia is quite common in IMN. However, the utility of the lipid profile in predicting outcomes remains unknown. This study aimed to explore the correlation between hyperlipidemia and proteinuria remission in IMN.
256 patients who diagnosed with IMN confirmed by renal biopsy in Wuhan Tongji Hospital from January 2016 to October 2020 were included in this study. The end point was defined as a combination of partial and complete remission. Cox proportional-hazards regression analysis and Kaplan-Meier curve were applied to assess the prognostic value of the lipid profile for proteinuria remission.
A total of 153 (59.8%) patients achieved remission and 103 (40.2%) did not. The levels of total cholesterol, low-density lipoprotein, and non-high-density lipoprotein were significantly lower in the remission group than in the non-remission group. Non-high-density lipoprotein level revealed the strongest correlation with proteinuria (Spearman's rho = 0.42; P < 0.001). The multivariate analysis demonstrated that serum total cholesterol [hazard ratio (HR): 0.883; 95% confidence interval (CI): 0.813-0.958; P = 0.003] and non-high-density lipoprotein cholesterol (HR: 0.892; 95% CI: 0.820-0.970; P = 0.007) levels were independent markers to predict proteinuria remission in IMN.
Among the lipid profile, the non-high-density lipoprotein level exhibited the strongest correlation with proteinuria in IMN. Moreover, elevated serum cholesterol and non-high-density lipoprotein cholesterol concentrations at baseline predicted probability of proteinuria non-remission in IMN.
特发性膜性肾病(IMN)可能有多种临床结局。高脂血症在 IMN 中很常见。然而,血脂谱在预测结局方面的作用尚不清楚。本研究旨在探讨 IMN 中高脂血症与蛋白尿缓解之间的相关性。
纳入 2016 年 1 月至 2020 年 10 月在武汉同济医院经肾活检确诊为 IMN 的 256 例患者。终点定义为部分缓解和完全缓解的组合。应用 Cox 比例风险回归分析和 Kaplan-Meier 曲线评估血脂谱对蛋白尿缓解的预后价值。
共有 153 例(59.8%)患者达到缓解,103 例(40.2%)未达到缓解。缓解组总胆固醇、低密度脂蛋白和非高密度脂蛋白水平明显低于未缓解组。非高密度脂蛋白水平与蛋白尿相关性最强(Spearman's rho=0.42;P<0.001)。多变量分析表明,血清总胆固醇[风险比(HR):0.883;95%置信区间(CI):0.813-0.958;P=0.003]和非高密度脂蛋白胆固醇(HR:0.892;95%CI:0.820-0.970;P=0.007)水平是预测 IMN 蛋白尿缓解的独立标志物。
在血脂谱中,非高密度脂蛋白水平与 IMN 中的蛋白尿相关性最强。此外,基线时血清胆固醇和非高密度脂蛋白胆固醇浓度升高预示着 IMN 中蛋白尿缓解率低。